Abstract
The accounting approach and DCF principles are now applied to five case studies, an IT project, a power gas generator, a pharmaceutical company, a growth firm and a firm abandonment. The first two case studies are considered from a management viewpoint, while the remaining three are from an investor’s perspective.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baldwin, C. and Clark, K. Design Rules: The Power of Modularity, MIT Press, 1999.
Berger, P., Ofck, E. and Swary, I. Investor Valuation of the Abandonment Option, Journal of Financial Economics 42: 257–87, 1996.
Challa, R. Discovering multiple interacting options, Energy and Power Risk Management, July 2000.
Clewlow, L. and Strickland, C. Energy Derivatives, Pricing and Risk Management, Lacima, 2000.
DiMasi, J., Hansen, R., Grabowski, H. and Lasagne, L. Cost of innovation in the pharmaceutical industry, Journal of Health Economics, 10(2): 107–42, 1991.
Dupont-Roc, G. The Evolution of the World’s Energy Systems, 1994.
Economides, M. and Oligney, R. The Color of Oil, Round Oak Publishing, 2000.
Grabowski, H.C. and Vernon, J.M. Returns to R&D on new drug introductions in the 1980s, Journal of Health Economics, 13: 383–406, 1994.
Grant, R. Contemporary Strategy Analysis, Blackwell, 2006.
Hamel, G. Leading the Revolution, Harvard Business School Press, 2000.
Hirsh, R. Power Loss, MIT Press, 1999.
Hooke, J. Security Analysis on Wall Street, Wiley, 1998.
Jones, J. What You Should Know about the Newspaper Industry, Frontline, PBS.
Kellogg, D. and Charnes, J.M. Real options valuation for a biotechnology company, Financial Analysts Journal, May/June, 2000.
Kohut, A., Doherty, C., Dimock, M. and Keeter, S. Online Papers Modestly Boost Newspaper Readership, The Pew Reseach Center, 2006.
Kulatilaka, N., Balasubramanian, P. and Storck, J. Using real options to frame the IT investment problem, in Trigeorgis, L. (ed.) Real Options and Business Strategy, Risk Books, 1999.
Myers, S. and Howe, CA. Life Cycle Financial Model of the Pharmaceutical R&D Program on the Pharmaceutical Industry, Massachusetts Institute of Technology, 1997.
Myers, S. and Shyam-Sunder, L. Measuring pharmaceutical industry risk and the cost of capital, in Helms, R.B. (ed.) Competitive Strategies in the Pharmaceutical Industry, Washington, DC, American Enterprise Institute Press, 1996.
Penman, S. Financial Statement Analysis and Security Valuation, McGraw Hill/Irwin, 2004.
Rose, R. A Comprehensive Strategy for Federal Investment in Fuel Cell Technology and Fuel Infrastructure, Breakthrough Technologies Institute, Inc., 2003.
Rudie Harrigan K., Declining Demand, Divestiture, and Corporate Strategy, Beard, 2005.
Stowe J.D., Robinson, T.R., Pinto, J.E. and McLeavey, D.W. Equity Asset Valuation, Wiley, 2007.
Sullivan, K., Chalasani, P., Jha, S. and Sazawal, V. Software design as an investment activity: a real options perspective, in Trigeorgis, L. (ed.) Real Options and Business Strategy, Risk Books, 1999.
Thomsett, R. Third Wave Project Management, Prentice Hall — Yourdon Press, 1993.
US Congress, Office of Technology Assessment, Pharmaceutical R&D: Costs, Risks and Rewards, OTA-M-522, Washington DC: US Government Printing Office (February), 1993.
Copyright information
© 2009 Jamie Rogers
About this chapter
Cite this chapter
Rogers, J. (2009). Five Shareholder Value Case Studies. In: Strategy, Value and Risk. Palgrave Macmillan Finance and Capital Markets Series. Palgrave Macmillan, London. https://doi.org/10.1057/9780230353930_5
Download citation
DOI: https://doi.org/10.1057/9780230353930_5
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-36707-8
Online ISBN: 978-0-230-35393-0
eBook Packages: Palgrave Economics & Finance CollectionEconomics and Finance (R0)